Abstract

BackgroundNon-coding RNAs (ncRNAs) are emerging as key regulators of many cellular processes in both physiological and pathological states. Moreover, the constant discovery of new non-coding RNA species suggests that the study of their complex functions is still in its very early stages. This variegated class of RNA species encompasses the well-known microRNAs (miRNAs) and the most recently acknowledged long non-coding RNAs (lncRNAs). Interestingly, in the last couple of years, a few studies have shown that some lncRNAs can act as miRNA sponges, i.e. as competing endogenous RNAs (ceRNAs), able to reduce the amount of miRNAs available to target messenger RNAs (mRNAs).ResultsWe propose a computational approach to explore the ability of lncRNAs to act as ceRNAs by protecting mRNAs from miRNA repression. A seed match analysis was performed to validate the underlying regression model. We built normal and cancer networks of miRNA-mediated sponge interactions (MMI-networks) using breast cancer expression data provided by The Cancer Genome Atlas.ConclusionsOur study highlights a marked rewiring in the ceRNA program between normal and pathological breast tissue, documented by its “on/off” switch from normal to cancer, and vice-versa. This mutually exclusive activation confers an interesting character to ceRNAs as potential oncosuppressive, or oncogenic, protagonists in cancer. At the heart of this phenomenon is the lncRNA PVT1, as illustrated by both the width of its antagonist mRNAs in normal-MMI-network, and the relevance of the latter in breast cancer. Interestingly, PVT1 revealed a net binding preference towards the mir-200 family as the bone of contention with its rival mRNAs.

Highlights

  • Non-coding RNAs are emerging as key regulators of many cellular processes in both physiological and pathological states

  • Identification of miRNA-mediated messenger RNAs (mRNAs)/long non-coding RNAs (lncRNAs) interactions We analyzed a large dataset of tumor and matched normal samples of breast invasive carcinoma (BRCA) profiled for both gene and miRNA expression, obtained from The Cancer Genome Atlas (TCGA)

  • As discussed in details in the Methods section, we restricted our study to a total of 10492 mRNAs, 311 miRNAs and 833 lncRNAs

Read more

Summary

Introduction

Non-coding RNAs (ncRNAs) are emerging as key regulators of many cellular processes in both physiological and pathological states. The constant discovery of new non-coding RNA species suggests that the study of their complex functions is still in its very early stages This variegated class of RNA species encompasses the well-known microRNAs (miRNAs) and the most recently acknowledged long non-coding RNAs (lncRNAs). NcRNAs are of growing interest, as they have been found to be important regulators of gene expression in development, physiology, and, when dysfunctional, in the presence of disease This variegated class of RNA species encompasses the well-known miRNAs, as well as the most recently acknowledged lncRNAs. Discovered miRNAs are single-stranded short RNAs (∼22 nucleotides long) that post-transcriptionally regulate gene expression by translation inhibition or degradation of their target mRNAs [3,4,5,6]. Altered miRNA expression characterizes many human diseases and mounting evidence strongly links specific miRNAs to tumor initiation, progression and metastasis [9,10,11,12,13,14]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call